299. Cystic fibrosis
1,592 clinical trials,   1,539 drugs   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02950116 (ClinicalTrials.gov) | March 9, 2017 | 11/10/2016 | Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung Disease | Lung Clearance Index in Pediatric Patients With Obstructive Lung Disease | Asthma;Bronchiectasis;Cystic Fibrosis | Device: Perform three multiple breath nitrogen washout tests (N2-MBW-test) | Universitair Ziekenhuis Brussel | NULL | Terminated | 6 Years | 17 Years | All | 27 | N/A | Belgium |
2 | NCT00570349 (ClinicalTrials.gov) | July 2004 | 6/12/2007 | Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis | Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis | Cystic Fibrosis | Drug: Nitric Oxide for Inhalation;Drug: Nitrogen | Mallinckrodt | NULL | Completed | 12 Years | N/A | All | 18 | Phase 1;Phase 2 | United States |